Clinical Trial

Neuromodulation in Substance Use Disorders

Name: Neuromodulation in Substance Use Disorders — clinical trial record (NCT07010016)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to assess the safety and feasibility of FUS neuromodulation in participants with OUD and/or other SUDs.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-05-29.

Status change: Not Yet Recruiting → Active, Not Recruiting 2025-10-15

Trial Details

NCT Number	NCT07010016
Lead Sponsor	Manish Ranjan
Conditions	Substance Use Disorder
Enrollment	20 participants
Start Date	2025-08-07
Primary Completion	2027-07-30 (estimated)
Study Completion	2028-07-30 (estimated)
Updated on ClinicalTrials.gov	2025-10-20